Breaking News

CatSci Acquires Reach Separations

The acquisition enables CatSci to offer its global customers access to holistic chromatographic services.

Author Image

By: Charlie Sternberg

Associate Editor

CatSci Ltd, an innovation partner for medicines development, has acquired Reach Separations, a specialist chromatography provider for the analysis and purification of therapeutics. The acquisition was supported by Keensight Capital, a private equity manager dedicated to pan-European Growth Buyout investments. Headquartered in the United Kingdom, and with laboratories in both the UK and France, Reach Separations specializes in chromatography for the analysis and purification of chiral and ach...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters